Status:
COMPLETED
F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Lead Sponsor:
Seattle Nuclear Medicine
Conditions:
Cancer
Bone Metastases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to compare 18F-Fluoride PET bone scans to traditional 99mTc-MDP bone scan to determine if one is better for diagnosing bone metastases.
Detailed Description
Compare the diagnostic sensitivity, specificity, and accuracy of 18F-Fluoride PET bone scans versus traditional 99mTc-MDP bone scans for detecting bone metastases. Determine if there is a significant...
Eligibility Criteria
Inclusion
- Patient has cancer
- Has been referred for evaluation of bone metastases
- Patient or patient's legal representative can understand and consent to enrollment in the study
- Must be 18 years or older
- Can remain still during the scan (approximately one hour)
- Patient has Medicare
Exclusion
- Patient does not have Medicare
- Under the age of 18
- Cannot lie still for the necessary time
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
299 Patients enrolled
Trial Details
Trial ID
NCT01254929
Start Date
December 1 2010
End Date
March 1 2020
Last Update
March 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle Nuclear Medicine
Seattle, Washington, United States, 98104